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Background:	  Electroconvulsive	  therapy	  (ECT)	   is	  brain	  stimulation	  with	  a	  short	  controlled	  series	  of	  electrical	  
pulses	   co-­‐administered	   with	   intravenous	   anesthesia.	   Aims:	   The	   aim	   of	   this	   review	   is	   the	   evaluation	   of	  
electroconvulsive	   effect	   as	   a	   first	   and	   second	   choice	   psychiatric	   treatment	   associated	   with	   memory	  
impairment	   effects.	   Method:	   A	   literature	   review	   search	   took	   place	   between	   1989	   to	   2014,	   concerning	  
aspects	  and	  reports	  of	  ECT.	  Results:	  Specifically	  27	  studies	  were	  selected	  and	   in	  nine	  of	  those	  (33.3%)	  ECT	  
was	   used	   as	   a	   first	   choice	   treatment.	   Overall	   44%	   (12)	   of	   the	   papers	   resulted	   to	   noticeable	   cognitive	  
impairment	  and	  memory	  deficits.	  Conclusion:	  ECT	  is	  a	  life	  savor	  treatment	  for	  life	  threatening	  cases	  where	  
quick	   results	   are	  needed	  and	  where	  pharmacotherapy	  has	   failed,	   yet	  a	   large	  percentage	  of	   authors	   (44%)	  
conclude	  that	  cognitive	  side	  effects	  are	  noted	  after	  ECT	  sessions.	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Introduction	  
Despite	  the	  fact	  that	  ECT	  has	  a	  75	  year	  old	  
history	   the	   results	   of	   this	   method	   were	  
worldwide	   known	   just	   after	   1970.	   The	  
reasons	   for	   this	   acknowledgement	   are:	  
improved	  therapeutic	  methods,	   increased	  
security	  measures	  and	  controllable	  use	  of	  
anesthesia.	  One	  theory	  claims	  that	  seizure	  
activity	  caused	  by	  ECT	  duration,	  results	   in	  
alteration	   of	   brain	   chemical	  
neurotransmitters.	   Another	   theory	  
suggests	   that	   ECT	   treatments	   affect	   the	  
normality	   level	  of	  human	  brain	  hormones	  
which	   can,	   in	   turn,	   practically	   affect	  
patients’	   energy,	   sleep,	   appetite	   and	  
mood	   ups	   and	   downs	   according	   to	   ECT	  
Handbook1.	  	  
	  
Indications	  and	  choice	  treatment	  for	  ECT	  
According	   to	   American	   Psychiatric	  
Association,2	  indications	  listed	  for	  ECT	  and	  
especially	   the	   treatment	   of	   patients	   with	  
major	   depressive	   disorder	   include	  
psychotic	   depression,	   catatonic	   stupor,	  
severe	   suicidality,	   food	   refusal	   leading	   to	  
nutritional	   compromise	   and	   other	  
extreme	   psychiatric	   situations	   where	   a	  
rapid	   definitive	   response	   is	   required.	   The	  
Association	   also	   recommends	   ECT	   for	  
patients	   who	   have	   previously	   shown	   a	  
positive	  response	  to	   it	  and	  for	  those	  who	  
have	  medical	   conditions	   that	  prevent	   the	  
use	   of	   antidepressant	   medications	   and	  
finally	   where	   the	   risks	   of	   other	   available	  
therapies	   are	   greater	   than	   the	   risks	   of	  
ECT.3,4,5	  	  
	  
ECT	  choices	  of	  therapy	  
	  As	  it	  was	  previously	  mentioned	  numerous	  
trials	   have	   taken	   place	   in	   order	   to	   show	  
ECT	   indications	   and	   appliances	   in	  
psychiatry.	   ECT	   is	   considered	   as	   first	  
choice	  therapy	  in:	  
1. Severe	  depressive	  episode	  and	  severe	  
psychomotor	   retardation	   (relating	  
problems	   concerning	   food	   and	   water	  
intake	   and	   general	   patient	   physical	  
worsening).6	  
2. Treatment	   resistant	   depression	   in	  
patients,	   in	   other	   words	   failure	   to	  
respond	   to	   two	   consequent	   tricyclic	  
antidepressant	   cycles	   of	   standard	  
doses	  lasting	  6	  weeks	  or	  more.7,8,9	  
3. Stupor	   and	   catatonic	   depression	  
where	   the	   patient	   remains	   entirely	  
motionless,	   speechless	   and	   with	  
negativeness.10	  
ECT	  as	  a	  second	  choice	  treatment	  in:	  
1.	   Major	   depression	   in	   aged	   patients,	  
taking	   into	   account	   psychical	   illness	  
because	  of	  anesthesia	  related	  risks.11	  
2.	  Major	  maniac	   cases,	  which	  are	   related	  
with	   physical	   burnout	   life	   threatening	  
cases	  and	  did	  not	  respond	  to	  therapy.12	  	  
	  PERIOPERATIVE	  NURSING	  (2016),	  VOLUME	  5,	  ISSUE	  2	  
	  
ELECTROCONVULSIVE	  THERAPY	  EFFECTS	  ON	  COGNITION	  AND	  MEMORY	  AND	  NURSE’S	  ROLE.2016;5(2)	        105 
	  
3.	   Patients	   with	   schizophrenia	   where	  
clozapine	   therapy	   either	   seemed	  
inadequate	   or	   impossible	   to	   comply	  
with.13	  
4.	   Parkinson	   disease	   with	   decrease	   of	  
kinetic	  symptoms.14	  
1. Neuroleptic	   malignant	   syndrome	  
(NMS)	   with	   severe	   morbidity,	  
mortality	   and	   contradictory	   results.	  
15,16	  	  
2. Patients	   with	   both	   dementia	   and	  
depression.	  17	  
3. Down	  syndrome	  and	  specifically	  when	  
antlaaxonic	  arthritis	  is	  stable.	  18,19	  
4. Patients	   with	   both	   intellectual	  
disability	   and	   depression	   with	   better	  
response	  when	  biological	  or	  psychotic	  
features	  were	  present.20	  
	  
ECT	  process	  
ECT	   is	   administered	   with	   general	  
anesthesia	  and	  the	  electrode	  placement	  is	  
divided	  mainly	  in	  two	  categories:	  bilateral	  
and	   unilateral.	   In	   bilateral,	   electrode	  
patches	   are	   placed	   on	   both	   hemispheres	  
of	  patient	  head	  while	  electrical	  stimulus	  is	  
between	   25-­‐50mc	   to	   750-­‐800mc.	   In	  
unilateral,	   patches	   are	   placed	   in	   one	  
hemisphere	   and	   in	   many	   cases	   it	   is	  
preferred,	   because	   the	   unwanted	   effects	  
from	   ECT	   such	   as	   memory	   impairments	  
are	   scarce.	   Yet	   bilateral	   has	   a	   quicker	  
response	   and	   drives	   to	   full	   patient	  
recovery	   especially	   in	   cases	   such	   as	  
catatonia.	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  
	  
Number	  of	  ECT	  sessions	  
Minimum	  number	  of	  therapeutic	  sessions	  
is	   considered	   number	   six	   because	   from	  
this	  number	  and	  on	   clinical	   improvement	  
will	   or	   will	   not	   show.21	   Furthermore,	   the	  
number	  of	  sessions	  can	  also	  be	   limited	   in	  
order	   to	   control	   the	   unwanted	   effects	  
such	   as	  memory	   impairments	   from	   three	  
times	  a	  week	  to	  two	  according	  to	  therapy.	  
If	   temporary	   improvement	   is	   succeeded,	  
for	  example	  resolving	  catatonia	  syndrome	  
then	   therapeutic	   sessions	   continue	   to	   a	  
maximum	   of	   number	   12.	   Reasons	   for	  
exclusion	  from	  ECT	  sessions	  are	  according	  
to	   American	   Psychiatric	   Association,	  
conditions	   associated	   with	   increased	   risk	  
of	  appliance	  such	  as:	  severe	  pulmonary	  or	  
unstable	   cardiovascular	   disease,	   elevated	  
intracranial	   pressure,	   stroke,	   vascular	  
aneurysm	   and	   ASA	   (American	   Society	   of	  
Anesthesiologists)	  Class	  4	  or	  5.	  	   	   	  
	  
Nurse’s	  role	  
According	   to	   the	   ECT	   Handbook	   of	   the	  
Royal	  College	  (third	  edition)22	  some	  of	  the	  
nurse’s	   duties	   during	   an	   ECT	   session	   are	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basically	  to	  provide	  advanced	  clinical	  care	  
before,	   during	   and	   after	   ECT	   procedure,	  
reduce	   patient	   stress	   through	   adequate	  
patient	   information	   and	   support	   their	  
families	   during	   the	   whole	   process.	   In	  
order	   to	  achieve	   these	   tasks,	   a	  nurse	  has	  
to	   have	   a	   full	   knowledge	   of	   the	   adverse	  
effects,	   indications	   and	   contraindications	  
of	   ECT	   process.	   However	   nursing	  
education	   upon	   ECT	   appliance	   and	  
procedure	   are	   areas	   not	   fully	   addressed	  
according	  to	  Arkan,23	  Byrne24	  and	  Wood25.	  	  
If	  nurses	  were	  trained	  adequately	  in	  order	  
to	   make	   a	   difference	   in	   ECT	   procedure	  
then	   practically	   they	   could	   provide	  
adequate	  feedback	  to	  the	  patient,	  families	  
and	   ECT	   team	   as	   well.	   Consequently	   a	  
thorough	   report	   of	   ECT	   choice	   therapy,	  
stability	   and	   side	   effects	   provided	   to	   the	  
nurse’s	   specialized	   in	   ECT	   would	   be	   a	  
useful	   tool	   for	   better	   assessment	   and	  
documentation	  of	  the	  ECT	  procedure.26	  	  
	  
Aim	  
The	   aim	   of	   this	   paper	   is	   an	   informative	  
one,	   meaning	   to	   acknowledge	   and	  
evaluate	  a)	  when	  ECT	  is	  considered	  a	  first	  
and	   a	   second	   choice	   treatment	   and	   b)	  




For	   this	   review	   27	   literature	   reviews	   and	  
clinical	  trials	  were	   included.	  Papers	  which	  
did	  not	  refer	  to	  data	  such	  as	  ECT	  duration,	  
type	   and	   effects	   on	   memory	   were	  
excluded.	   Some	   of	   these	   studies	   though,	  
were	   used	   for	   bibliography	   reasons.	   The	  
author	   searched	   Medline,	   Embase	   and	  
Cochrane	   Register	   of	   Clinical	   Trials	  
including	   studies	   between	   1989	   to	   2014.	  
Key	   words	   which	   were	   used	   were:	   ECT	  
guidelines,	   ECT	   therapy,	   ECT	   treatment	  
and	   combination	   of	   the	   previous.	  
Specifically	  44	  studies	  were	   identified	  but	  
only	   27	   were	   used,	   those	   which	   were	  
relevant	   to	   the	   topic.	   Additionally	   this	  
paper	  uses	  a	  dimensional	  approach	  rather	  




According	   to	   the	   results	   a	   total	   of	   27	  
different	   papers	   were	   included.	  
Parameters	   such	   as	   whether	   ECT	   was	  
considered	   a	   first	   or	   second	   choice	  
treatment,	   stability,	   memory	   and	  
cognition	   effect,	   ECT	   type	   of	   appliance	  
(bilateral	   or	   unilateral),	   study	   type	   and	  
number	   of	   participants	   were	   inserted	   to	  
the	  study.	   	   	   	   	   	   	  	   	   	  	  	  	  	  	  	  	  	  	  	  	  
More	   specifically	   it	   was	   indicated	   that	   in	  
33.3%	   (n=9)	  of	   the	  studies,	  ECT	  was	  used	  
as	   a	   first	   choice	   treatment	   for	   major	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depression,	   treatment	   resistant,	   or	  
catatonic.	   There	   was	   also	   another	   26%	  
(n=7)	  of	  the	  studies	  in	  which	  ECT	  was	  used	  
as	   a	   second	   choice	   treatment	   in	   major	  
depression	  in	  the	  elderly	  after	  one	  or	  two	  
cycles	   of	   pharmacotherapy	   while	   in	   the	  
rest	  papers	  	  37%	  (n=10)	  ECT	  was	  a	  second	  
choice	   therapy	   in	   schizophrenia,	   mania	  
etc.	   	   Additionally	   only	   9	   papers	   (33%)	  
of	   the	   total	   referred	   to	   stability	   of	   the	  
antidepressant	   response	   induced	   by	   ECT	  
and	  among	   these	  at	   least	  3	  papers	   (11%)	  
showed	   stability	   which	   lasted	   from	   6	  
months	  to	  two	  years	  whereas	  in	  the	  other	  
6	   papers	   (22%),	   stability	   effect	   was	  
shorter	   than	   6	   months.	   Memory	   and	  
cognition	   impact	   were	   observed	   in	   66%	  
(n=18)	   of	   the	   studies.	   	   It	   was	   found	   that	  
around	   44%	   (n=12)	   of	   the	   papers	  
mentioned	   adverse	   effects	   such	   as	  
amnesia	  or	  claimed	  cognitive	  impairments	  
while	   in	   the	   rest	  22%	   (n=6)	   improvement	  
was	   noted.	   Resolution	   of	   dementia	  
symptoms	   and	   cognitive	   improvement	  
were	  also	  found	  when	  ECT	  was	  applied	  in	  
neurological	  diseases	  such	  as	  Alzheimer	  in	  
7%	  (n=2).	  Finally	  nearly	  37%	  (n=10)	  of	  the	  
papers	   are	   referring	   to	   the	   type	   of	   the	  
stimulus	   electrodes	   used	   (bilateral	   and	  
unilateral)	   and	   from	   those	   29.6%	   (N=8)	  
mentioned	   that	   there	   was	   greater	  
impairment	  in	  bilateral	  than	  in	  unilateral.	  
	  
Discussion	  
As	   foretold	   this	   study	   is	   an	   effort	   to	  
explore	   different	   and	   similar	   views	   of	  
authors	   concerning	   ECT,	   as	   great	  
controversy	   exists	   considering	   the	  
difference	   between	   bilateral	   and	  
unilateral	   ECT,	   duration	   of	   therapeutic	  
results	  and	  cognitive	  effects	  in	  memory.	  A	  
lot	  of	  psychiatrists	  use	  ECT	  as	  a	  first	  choice	  
treatment	   in	   catatonia	   and	   as	   a	   second	  
choice	   treatment	   after	   one	   or	   two	   cycles	  
of	   pharmacotherapy	   and	   especially	  when	  
drugs	   do	   not	   have	   the	   immediate	   results	  
patients	   and	   psychiatrists	   long	   for.	   As	  
reported	   by	   Bush27	   the	   motor	   signs	   of	  
catatonia	  can	  be	  relieved	  by	  sedatives	  and	  
two	   sessions	   of	   ECT,	   a	   method	   which	   is	  
considered	   ineffective	   for	   schizophrenia.	  
Additionally	  ECT	   is	  a	   therapy	  mainly	  used	  
for	   resistant	   depression.	   When	   the	  
adequate	   drug	   dose	   is	   not	   enough	   and	  
patient	   compliance	   is	   an	   issue	   then	   a	  
depressive	   disorder	   diagnosis	   is	   defined.	  
Nowadays	  however	  there	  are	  not	  so	  many	  
solutions	  to	  confront	  resistant	  depression.	  
ECT	   was	   and	   still	   remains,	   psychiatrists’	  
last	  choice	  of	  treatment.	  Furthermore	  this	  
study	   is	   also	   in	   agreement	   to	   Pagnin,28	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who	   considers	   ECT,	   a	   valid	   therapeutic	  
choice	  treatment	  for	  depression.	  
	   However	   relapse	   or	   recurrence	   of	  
psychiatric	  symptoms	  are	  common,	  but	  so	  
is	   patient	   response	   to	   treatment.	   The	  
stability	  of	  response	  of	  this	  review	  agrees	  
also	   with	   Segman21	   where	   relapse	   rate	  
may	   exceed	   50%	   in	   the	   first	   3	   months.	  
Tharyan29	   in	   a	   previous	   study	   also	  
suggests	   that	   generally	   people	   with	  
schizophrenia	   can	   be	   improved	   in	   short	  
term	   with	   ECT	   but	   combination	   with	  
pharmacotherapy	   after	   the	   end	   of	   the	  
treatments	   also	   helps.	   Individual	   patient	  
characteristics	   must	   also	   be	   explored	   in	  
order	   to	   predict	  which	   therapy	   suits	   best	  
with	   each	   patient	   according	   to	   Kellner.30	  
Additionally	   there	   are	   other	   factors	   that	  
are	   related	   with	   relapse	   rate	   such	   as	  
continuous	   monotherapy	   or	   combination	  
of	   antidepressant	   medication	   before	   and	  
after	   ECT,	   period	   of	   trial	   and	   quick	  
response	  to	  ECT,	  parameters	  that	  are	  not	  
taken	  into	  account	  in	  the	  specific	  study.	   	  
	   It	   may	   be	   questioned	   whether	   the	  
choice	  of	   ECT	   (bilateral	   or	   unilateral)	   had	  
any	   effects	   on	   cognition.	   	   Robertson31	  
suggests	   that	   the	   significance	   of	   amnesia	  
depends	   on	   different	   factors	   such	   as	   the	  
exact	   time	   the	   patient	   has	   been	   tested	  
after	   ECT	   for	   example	   three	   hours	   or	   24	  
hours	   afterwards,	   whether	   he/she	   has	  
taken	   an	   IQ	   test	   beforehand	   and	   if	   there	  
was	  any	  memory	  assessment	  after	  at	  least	  
6	  months	  to	  a	  year	  as	  it	  allows	  for	  optimal	  
identification	   of	   permanent	   cognitive	  
deficits	   and	   better	   assessment	   of	  
retrograde	  amnesia.	  	  Among	  limitations	  of	  
this	   literature	   review	   were,	   differences	  
among	  patients	  in	  the	  treatment	  received	  
which	  were	   not	   determined	   such	   as	   age,	  
gender,	  number	  of	   administered	  ECT	  and	  
level	  of	  dosage,	  factors	  that	  contribute	  to	  
greater	   cognitive	   deficit	   but	   the	   study	  
generally	   agrees	   with	   the	   fact	   that	  
bilateral	   electrode	   placement	   resulted	   in	  
more	   severe	   and	   persistent	   cognitive	  
deficits.32	   Additionally	   this	   paper	   agrees	  
with	   Rose	   et	   al.,33	   and	   Service	   User	  
Research	   Institute34	   where	   cognitive	  
impairment	  and	  memory	  loss,	  affects	  30%	  
of	  the	  patients.	  Tharyan35	  in	  a	  future	  study	  
also	   implies	   a	   slight	  memory	   impairment	  
resulting	   from	   ECT	   without	   referring	   to	  
the	  electrode	  placement	  while	  O’Connor36	  
supports	  the	  conclusion	  that	  bilateral	  is	  so	  
effective	   in	   controlling	   depression	   as	  
median	  dosed	  unilateral	  ECT.	  Furthermore	  
as	   foretold	   this	   paper	   agrees	   also	   with	  
Sackeim37	  who	  claims	  that	  high	  dosage	  of	  
unilateral	   ECT	   is	   as	   effective	   as	   bilateral	  
but	   produces	   less	   severe	   and	   less	  
persistent	  cognitive	  effects.	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   In	   conclusion	   when	   it	   comes	   to	   speak	  
about	   ECT	   it	   has	   to	   be	   understood	   that	  
when	   psychiatrics	   want	   to	   minimize	   the	  
intellectual	  side-­‐effects	  of	  treatment,	  then	  
unilateral	  ECT	   is	  preferable.	  On	   the	  other	  
hand	   when	   the	   speed	   of	   clinical	  
improvement	   is	   paramount	   as	   in	   life-­‐
threatening	   depressive	   illness,	   then	  
bilateral	  ECT	  may	  be	  preferred.38	  However	  
prospective	  patients	  should	  be	  warned	  of	  
the	  significant	   risk	  of	  permanent	  amnesia	  
and	  the	  possibility	  of	  permanent	  memory	  
and	  cognitive	  disability.	  Rose39	  also	  refers	  
to	   the	   information	   provision	   procedures	  
of	  the	  patients	  who	  are	  receiving	  ECT	  and	  
approximately	   30%	   of	   them	   believe	   that	  
they	   have	   been	   induced	   to	   have	   the	  
treatment.	  	  
	   Fisher40	   additionally	   claims	   that	  
consenting	  to	  ECT	  should	  change	  because	  
patients	   agree	   that	   they	   feel	   a	   lack	   of	  
choice.	   One	  way	   to	   overcome	   this,	   is	   for	  
health	   personnel,	   such	   as	   nurses,	   to	   be	  
educated	  as	  mentioned	  above	  and	  inform	  
psychiatric	   patients	   properly	   before	  
signing	   an	   informed	   consent.	   It	   is	   also	  
suggested	   that	   psychiatric	   assessment	   of	  
patient’s	  self-­‐reports	  of	  memory	  difficulty	  
could	   be	   incorporated	   throughout	   ECT	  
course	   (meaning	  before,	  during	  and	  after	  
ECT	   treatment)	   in	   order	   to	   detect	   ECT-­‐
related	   cognition	   changes41	   and	   so	   end	  




Prior	   of	   ECT,	   legal	   issues	   arise,	   such	   as	  
patient	   consent	   mainly	   in	   people	   with	  
learning	   disabilities	   which	   are	   deprived	  
from	   the	   ability	   to	   give	   an	   informed	  
consent.	   In	   these	   cases	   doctors	   should	  
evaluate	   patient’s	   ability	   to	   uphold	   and	  
understand	   the	   information	   for	   a	   specific	  
amount	  of	  time	  prior	  to	  the	  final	  decision.	  
Yet	   in	  cases	  of	  emergency,	  ECT	   is	  applied	  
without	   the	   patients’	   consent	   as	   it	   is	  
considered	   a	   first-­‐line	   treatment,	  
especially	   when	   a	   person	   is	   suicidal,	  
psychotic,	   not	   eating	   or	   catatonic	  
(immobile).	  In	  any	  other	  case	  the	  patients	  
should	  be	  adequately	  informed	  about	  the	  
benefits	   and	   side	   effects	   of	   ECT	   before	  




Despite	   the	   fact	   that	   ECT	   has	   proved,	  
throughout	   the	   years,	   to	   be	   helpful	  
towards	  patient’s	  psychiatric	  treatment,	  it	  
is	  mentioned	   that	   its	   impact	   on	   patient’s	  
life	   can	   have	   a	   detrimental	   effect.	  
Memory	   loss	   was	   and	   still	   remains,	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unfortunately,	   one	   of	   ECT’s	   well	   known	  
outcomes.	   Further	   research	   should	   take	  
place	   in	   order	   to	   minimize	   knowledge	  
deficits	   after	   ECT	   sessions.	   	   Health	  
professionals	   should	   be	   more	   careful	  
about	   informed	   consent	   in	   order	   to	  
achieve	   maximum	   care	   and	   patient	  
satisfaction.	   In	   this	   way	   ECT	   treatment	  
could	   result	   to	   a	   therapeutic	   mean	  
without	  any	  poor	  consequences.	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